We understand that there are regulations for NHPs, and they're different from those for pharmaceutical medications and are designed differently, and we support that.
Also, Vanessa's Law brought in new tools and new authorities that would benefit NHPs. One of them is the reporting of serious adverse reactions, and the other is a label change such that maybe you don't need a recall. I agree that many recalls are voluntary and many label changes are voluntary, but it's not always the case. Imagine that Health Canada can't say, “We've learned about this and this needs to be added to the label” or—